AUD295.62
0.37% day before yesterday
Australia, Dec 27, 06:10 am CET
ISIN
AU000000COH5
Symbol
COH
Sector

Cochlear Stock price

AUD295.62
-10.24 3.35% 1M
-28.19 8.71% 6M
+0.91 0.31% YTD
-0.04 0.01% 1Y
+88.20 42.52% 3Y
+77.04 35.25% 5Y
+228.04 337.42% 10Y
Australia, Closing price Fri, Dec 27 2024
-1.10 0.37%
ISIN
AU000000COH5
Symbol
COH
Sector

Key metrics

Market capitalization AUD19.29b
Enterprise Value AUD19.02b
P/E (TTM) P/E ratio 54.30
EV/FCF (TTM) EV/FCF 58.28
EV/Sales (TTM) EV/Sales 8.42
P/S ratio (TTM) P/S ratio 8.54
P/B ratio (TTM) P/B ratio 10.49
Dividend yield 1.39%
Last dividend (FY24) AUD4.10
Revenue growth (TTM) Revenue growth 15.47%
Revenue (TTM) Revenue AUD2.26b
EBIT (operating result TTM) EBIT AUD521.50m
Free Cash Flow (TTM) Free Cash Flow AUD326.40m
EPS (TTM) EPS AUD5.44
P/E forward 45.85
P/S forward 7.86
EV/Sales forward 7.75
Show more

Is Cochlear a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Cochlear Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Cochlear forecast:

1x Buy
13%
5x Hold
63%
2x Sell
25%

Analyst Opinions

8 Analysts have issued a Cochlear forecast:

Buy
13%
Hold
63%
Sell
25%

Financial data from Cochlear

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
2,258 2,258
15% 15%
100%
- Direct Costs 562 562
15% 15%
25%
1,696 1,696
16% 16%
75%
- Selling and Administrative Expenses 813 813
11% 11%
36%
- Research and Development Expense 277 277
13% 13%
12%
606 606
23% 23%
27%
- Depreciation and Amortization 85 85
5% 5%
4%
EBIT (Operating Income) EBIT 522 522
26% 26%
23%
Net Profit 357 357
19% 19%
16%

In millions AUD.

Don't miss a Thing! We will send you all news about Cochlear directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Head office Australia
CEO Diggory Howitt
Employees 5,000
Founded 1983
Website www.cochlear.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today